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LETTER TO THE EDITOR
Journal  of  the College of  Physicians and Surgeons Pakistan 2020,  Vol.  30(09):  10021002
Vitamin D Usage among Pakis-
tani Population – Too Much of
a Good Thing
Sir,
Vitamin D deficiency (VDD) is one of the most common nutri-
tional  disorders  worldwide.  This  is  also  true  in  Pakistan  as
reported by Riaz and colleagues in their study, revealing VDD in
53.5% and insufficiency in 31.2% study participants.1 There is
growing awareness of VDD in the Pakistani population, which
has resulted in vitamin D becoming a popular supplement in the
community and is being used as one of the most common over
the  counter  medicines.  It  is  also  being  prescribed  more
frequently  by  physicians;  with  supplements  ranging  from
vitamin D capsules to high dose (50,000 IU, 200,000 IU, and
600,000  IU)  injections.  Sometimes,  these  are  continued  for
indefinite periods without baseline checking or follow-up moni-
toring of 25-OH vitamin D levels.
As a result of this increased consumption of vitamin D supple-
ments by the general population and overcorrection of VDD by
some healthcare practitioners, it is becoming a leading cause of
hypervitaminosis D and hypercalcemia, also called as vitamin D
toxicity  (VDT).2,3  In  literature,  VDT  has  been  reported  from
various  parts  of  the  world  to  be  associated  with  significant
morbidity and mortality.4 We are also witnessing many patients
referred to our clinics and also as inpatient with VDT and serious
problems. The true prevalence of VDT in the Pakistani popula-
tion is not known so far, but is not uncommon, as reported by
Khan et  al;5  27% of  their  patients  with  hypercalcemia  were
found to have VDT, where multiple high dose injections were
given weekly to these patients for six to eight weeks.5 Our intent
in  sending  this  communication  is  to  help  create  awareness
amongst health professionals regarding VDT and appropriate
replacement of vitamin D based on baseline 25-OH vitamin D
levels, age and associated risk factors. Furthermore, general
public should also be educated about the toxic consequences of
this over the counter medicine.
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